Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Shuai Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5238-071X; OpenAlex author ID A5102710503. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 5

  1. The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.933645↗
  2. Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition. Co-author DOI 10.3389/fonc.2021.762233↗
  3. Role of non-coding RNA in pancreatic cancer. First author DOI 10.3892/ol.2019.10758↗
  4. miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. Co-author DOI 10.1038/cddis.2017.530↗
  5. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review. First author DOI 10.1155/2017/2646148↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kai Luo · 2 shared papers, 2021–2022 · strength 0.34
  2. Yinghao Lv · 1 shared paper, 2019 · strength 0.20
  3. Renfeng Li · 1 shared paper, 2022 · strength 0.19
  4. Jianhua Jiang · 1 shared paper, 2021 · strength 0.16
  5. Shuai Wang · 1 shared paper, 2017 · strength 0.12
  6. Yuling Sun · 1 shared paper, 2017 · strength 0.12
  7. Manmei Long · 1 shared paper, 2017 · strength 0.06
  8. Ming Zhan · 1 shared paper, 2017 · strength 0.06
  9. Jian Wang · 1 shared paper, 2017 · strength 0.06
  10. Qiang Liu · 1 shared paper, 2017 · strength 0.06
  11. Linhua Yang · 1 shared paper, 2017 · strength 0.06
  12. Ruimeng Yang · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.